Cleared Traditional

K924091 - EBV-VCA IGG ELISA TEST SYSTEM (FDA 510(k) Clearance)

Jan 1993
Decision
151d
Days
Class 1
Risk

K924091 is an FDA 510(k) clearance for the EBV-VCA IGG ELISA TEST SYSTEM. This device is classified as a Antigen, Ebv, Capsid (Class I - General Controls, product code MCD).

Submitted by Zeus Scientific, Inc. (Raritan, US). The FDA issued a Cleared decision on January 11, 1993, 151 days after receiving the submission on August 13, 1992.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3235.

Submission Details

510(k) Number K924091 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 1992
Decision Date January 11, 1993
Days to Decision 151 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code MCD — Antigen, Ebv, Capsid
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3235